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Immunization with a foreign protein stimulates the production of a heterogeneous 
group of immunoglobulins differing in class, allotype, and avidity for specific antigen. 
Studies with hapten-protein conjugates have demonstrated a wide range of hapten- 
binding energies  among subfractions of a single antiserum (1, 2). After immunization, 
the average affinity for hapten increases with time and the rate of increase can be 
maximized with an optimal immunizing dose (3).  Conversely, the antibody produced 
by partially tolerant animals is of low average affinity (4-6). 
Siskind  and Benacerraf  (7)  have proposed that  the  increase  of antibody affinity 
observed after  immunization reflects  the  selective pressure  of antigen  on a  hetero- 
geneous population of immunocytes, each bearing a  surface receptor resembling  the 
antibody it will  synthesize.  According to  their  model,  cells  with  receptors  of high 
affinity proliferate  at low antigen  concentration, whereas  cells  with low affinity re- 
ceptors require high levels of antigen for comparable stimulation.  As the concentra- 
tion of available antigen falls  progressively after sensitization,  proliferation  of high 
affinity cells would be favored, accounting for the observed increase in average affinity 
of circulating antibody. Conversely, if tolerance is induced with a large dose of antigen, 
cells  of high affinity,  capable  of binding antigen  most avidly, would be selectively 
suppressed. 
Evidence  for  heterogeneity  among  antigen-sensitive  cells  has  been  drawn  from 
observations in vivo of cross-reactivity between closely related hapten-protein con- 
jugates and from the dose-response characteristics of cell-mediated reactions (8-16). 
In vitro studies by Paul et al.  (10)  have demonstrated a gradual and progressive in- 
crease of thymidine incorporation by sensitized lymphocytes on exposure to specific 
antigen over an extremely wide range of concentration. Immunization with high doses 
of antigen, known to evoke antibody of low average affinity, selected a population of 
* This work was supported by U.S. Public Health Service Grant AI-09529, by American 
Cancer Society (Massachusetts)  Grant 1369-C-1, and by General Research Support Funds. 
Postsophomore  Fellow, U.S. Public Health Service, and  Student  Research Fellow, the 
Lily Research Laboratories. Present Address: Harvard Medical School, Boston, Mass. 
§ Career Development  Award 1-K04-AI-46 352-01 recipient, U.S. Public Health Service. 
Formerly, Fellow, The Medical Foundation, Inc., Boston, Mass. 
187 188  HETEROGENEITY  OF  THE  CELLULAR  IMMUNE  RESPONSE.  I 
cells requiring  high  concentrations  of  antigen  for  optimal  stimulation  in  culture. 
Sensitization with smaller amounts of antigen permitted optimal reactivity at lower 
antigen concentration,  associated with antibody of high average affinity. However, 
these authors  did not  detect a  fall in  the antigen concentration necessary to elicit 
minimal or half-maximal stimulation at  late  intervals following sensitization, cor- 
responding to the marked increase in antibody affinity observed over the same period. 
In  this  paper  we provide  additional evidence for  heterogeneity in  the  re- 
sponse of lymph node cells from sensitized and tolerant guinea pigs. An evolu- 
tion of cellular reactivity was observed after immunization with human serum 
albumin (HSA) I in Freund's complete adjuvant, and this evolution was retarded 
by  the  induction  of  tolerance.  Antigen-specific stimulation  of  th)Taidine  in- 
corporation occurred at progressively lower concentrations of HSA at successive 
intervals  following  sensitization,  associated  with  a  concomitant  increase  in 
the magnitude  of maximal stimulation. Lymph  node  cells from  animals ren- 
dered  tolerant  to  HSA  failed  to  react  with  specific  antigen  in  culture.  As 
tolerance waned,  reactivity was first observed at high, but not at low antigen 
concentrations.  Finally, the dissociation of delayed hypersensitivity and  anti- 
body formation observed early in the immune response and on recovery from 
tolerance  has  provided  further  correlation  of  lymphocyte  stimulation  with 
delayed cutaneous reactivity (17,  18). 
Materials  and Methods 
Antigens.--HSA,  crystallized, lots 24-27, was obtained from Pentex, Inc., Kankakee, Ill. 
Preservative-free purified protein derivative (PPD) was the generous gift of Parke, Davis & 
Co., Inc., Detroit, Mich. Old tuberculin (OT) was supplied by the Massachusetts Department 
of Health. Antigens were dissolved in either sterile pyrogen-free saline or in Eagle's minimum 
essential medium with glutamine (MEM)  (Grand Island Biological Co., Grand Island, N.Y.) 
and were passed through a sterile 0.22 # Millipore filter that had been washed exhaustively to 
remove contaminating detergent (19). 
Immunization  of Guinea  Pigs.--450-500  g  male Hartley guinea pigs  (Camm  Research 
Institute, Inc., Wayne, N.J.)  received  10/zg HSA emulsified in 0.1  ml complete  Freund's 
adjuvant (CFA) divided among the four footpads. Control groups received 0.1 ml CFA with- 
out HSA. CFA contained 50 parts saline, 42.5 parts Bayol 55  (Esso Chemical Co., Rahway, 
N.J.), 7.5 parts Arlacel A (Hilltop Laboratories, Inc., St. Paul, Minn.), and tubercle bacilli 
(human  strains C, DT, and PN, Mass. Dept. of Health) to provide a final concentration of 3 
mg/ml. In some experiments  the concentration of bacilli was reduced  10-fold to 300 #g/ml 
(CFA 1  : 10). Tolerance was produced  by the intravenous injection of either 500 #g or 5 rag 
HSA in 1.0 ml saline, immediately before immunization with the same antigen in adjuvant 
(20). 
Skin  Tests  and Antibody Assay.--Skin  tests were performed  by the intradermal injection 
of 0.1 ml of saline containing either 6 #g HSA or 1:100 OT. Reactions were read at 24 hr, 
1 A bbrcviations used in this paper:  CBH, cutaneous  basophil hypersensitivity; CFA, com- 
plete Freund's adjuvant; dpm, disintegrations per minute; HSA, human  serum  albumin; 
MEM, Eagle's minimal essential medium; NGPS, normal guinea pig serum; OT, old tubercu- 
lin; PCA, passive cutaneous  anaphylaxis; PPD, preservative-free purified protein derivative. R.  C.  BAST~ JR.,  E.  ]'.  MANSEALT~ AND  H.  F.  DVORAK  189 
recording the diameter and intensity of erythema, the extent of induration (0 to 4+), and 
the presence or absence of necrosis. For histologlc examination, skin reactions were excised 
following sacrifice and 1/z sections prepared (21). 
Sera were assayed by passive hemagglutination which detected both 7S~,1 and 7S'y2 anti- 
bodies.  7S~,2 antibodies were  assayed directly by passive hemolysis; 7S~,1 antibodies were 
measured by passive cutaneous anaphylaxis and in some cases by systemic anaphylaxis fol- 
lowing intravenous challenge with 5 mg HSA. 
Lymphocyte Culture.--Guinea pigs were anesthetized with ether and exsanguinated. Sub- 
scapular,  axillary,  inguinal, femoral,  and popliteal lymph nodes were  excised with aseptic 
technique and placed in MEM containing penicillin and streptomycin. Nodes trimmed of fat 
were transferred to  antibiotic-free MEM  supplemented with  10% heat-inactivated normal 
guinea pig serum (NGPS). Cells were teased into suspension, filtered through sterile 100 mesh 
wire cloth, and ~ashed three times in MEM with 10% NGPS with centrifugation at 800 
rpm for 10 min at ambient temperature. After a final resuspension in MEM with serum, cells 
were counted and viability assessed with 0.1% try-pan blue. An average of 570 X  106 lymph 
node cells were isolated per animal with a mean viability of 63%. No significant difference in 
total cell yield per animal was found among different experimental groups. Replicate cultures 
were prepared in 16 X  125 mm plastic culture tubes (Falcon Plastics, Los Angeles, Calif.). 
Each contained 1 X  107 viable nucleated cells in a final volume of 2.5 ml. MEM supplemented 
with 20% NGPS, 100 units/ml penicillin and 100/zg/ml streptomycin. Log dilutions of HSA 
were prepared in 1% NGPS in saline. Appropriate amounts of HSA, PPD, or diluent were 
added to duplicate or triplicate cultures.  Following 48 hr incubation in 5% CO2-95%  air, 
4/zCi aH-thymidine was added to each culture. After an additional 24 hr of culture, cells were 
harvested by centrifugation at 1000 rpm for 15 rain at 4°C, washed twice in cold saline, and 
the pellet frozen and thawed three times. Cold  10% trichloracetic acid was added and the 
precipitate held overnight at 4°C. Tubes were centrifuged at 1500 rpm for 15 rain at 4°C and 
pellets dissolved in Hyamine hydroxide  --  10  X  (Packard Instrument Co., Inc., Downers 
Grove, Ill.)  at 37°C.  Solubilized cultures were transferred quantitatively to Bray's solution 
and  radioactivity was  measured  in  a  Packard  Tri-Carb  liquid  scintillation  spectrometer. 
Activities were converted to disintegrations per minute (dpm)  by reference to an external 
standard. 
In preliminary experiments HSA nonspecifically depressed thymidine incorporation of cells 
from animals immunized with CFA alone. This depression was dose dependent,  varied in 
extent with different lots, and was not eliminated by removal of lipid, endotoxin, or the low 
polymers of albumin known to contaminate commercial preparations (22, 23). The stimulatory 
response to PPD of cells from animals sensitized with CFA was abolished by the addition of 5 
mg/ml HSA whereas 1 mg/ml HSA had no significant effect. While a protein contaminant 
unique to preparations of HSA could contribute to this suppression (24), a  variety of com- 
mercially prepared protein antigens including bovine gamma globulin, ferritin, ovalbumin, 
and  keyhole limpet  hemocyanin depressed  thymidine uptake  of  CFA-sensitized  cells at  a 
concentration of 1 mg/ml, pointing to a less specific toxicity. To minimize the effect of non- 
specific toxicity, the response of sensitized or tolerant cells was compared to that of cells from 
animals receiving adjuvant alone. 
Analysis of Data.--Statistical  analysis of our data was performed with the kind assistance 
of Dr. John Gilbert. The mean of dpm for duplicate or triplicate cultures incubated with each 
concentration of antigen was divided by the mean of dpm incorporated by cells from the same 
animal grown in the absence of HSA. Ratios thus obtained from 5 to 12 sensitized or tolerant 
animals were compared to ratios from similar numbers of control animals immunized only 
with CFA or CFA 1 : 10. Differences between experimental and control groups were evaluated 
at each interval and for each concentration of antigen using the Mann-Whitney test  (25). I90  HETEROGENEITY  OF  THE  CELLULAR  IMMUNE  RESPONSE.  I 
A nonparametric method was chosen, as the variance of ratios from experimental and control 
groups  differed  significantly, prohibiting the use  of  the  more familiar t  test.  Statistically 
significant stimulation (P <  0.05) is indicated in Figs. 1 and 2 by the use of closed symbols. 
For  graphical presentation,  reactivity was  expressed  as  a  stimulatory index.  This was 
calculated for each time interval and antigen concentration by dividing the average ratio of 
stimulation in each experimental group  by the average ratio in the corresponding control 
group sensitized with adjuvant alone: 
dpm, HSA-CFA-sensitized cells cultured with HSA 
average 
dpm,  HSA-CFA-sensitized  cells  cultured  without  HSA 
stimulatory index  = 
dpm,  CFA-sensitized cells cultured with HSA 
average 
dpm, CFA-sensitized cells cultured without HSA 
Under favorable circumstances it was possible to detect significant antigen-induced stimu]a- 
tion with stimulatory indices of less than 2  (Figs. 1 and 2). 
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FIG.  1.  Stimulation  of  thymidine incorporation  in  draining  lymph  node  cells  cultured 
with different concentrations of antigen at  1, 2, and 4 wk after sensitization with 10 #g HSA 
in CFA. Each point here and  in Fig. 2 represents the mean stimulatory index determined 
from 5-12 guinea pigs sensitized with HSA in CFA, and from a comparable number of animals 
sensitized with CFA alone (see Materials and Methods). Each closed circle designates a sta- 
tistically significant difference (P  <  0.05)  between antigen-sensitized and adjuvant control 
groups. R.  C.  BAST~ JR.~  E.  J.  MANSEAU~ AND  H.  F.  DVORAK  191 
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Fie. 2.  Stimulation of thymidine incorporation in draining lymph node cells cultured with 
different concentrations of HSA at 2, 4, and 8 wk after sensitization with or without an intra- 
venous suppressing injection: ©--O,  Cells from animals sensitized with 10 #g HSA in CFA 
or CFA 1:10, as indicated. V].-. I, Cells from animals receiving a 5 mg suppressing injection 
of HSA at the time of sensitization. A- -A, Cells from animals receiving a 500 #g suppressing 
injection of HSA  at the time of sensitization. Each dosed symbol designates a  statistically 
significant difference (P <  0.05)  from the adjuvant control group. 192  HETEROGENEITY  OF  THE  CELLULAR  IMMUNE RESPONSE.  I 
Antigen Carry-Over.--At the time of sacrifice, a certain amount of HSA delivered with the 
sensitizing and/or suppressing injections remained within draining lymph nodes. Since  the 
response of cultured cells proved to vary directly with antigen concentration, it was important 
to demonstrate that significant quantities of antigen were not transferred to cultures with 
washed cells. All animals were placed on drinking water containing potassium iodide several 
days before injection. Five animals were sensitized with 10  /zg 125I trace-labeled HSA  (26) 
in CFA and another five received a  5 mg suppressing injection of 1~5I HSA at the time of 
sensitization with 10 #g unlabeled HSA in CFA. In each case,  125I HSA with a specific activity 
of 200/zCi/mg was diluted with appropriate amounts of unlabeled HSA. 2 wk later, lymph 
nodes were minced, cells were washed according to the tissue culture protocol, and counted 
in a Packard autogamma spectrometer. 
An average of 4.5 ng HSA was associated with the washed lymph node cells of each animal 
sensitized with 10 #g labeled HSA in CFA. Less than 1 ng HSA was bound following an intra- 
venous suppressing injection of labeled HSA at the same interval. Assuming that these accu- 
mulations are additive, the washed lymph node cells from a single animal receiving both sup- 
pressing and sensitizing injections would contain 5.5 ng HSA. Since each culture contained 
less than ~0th of the viable cells harvested from an animal, a maximum of 0.2 ng of antigen 
would have been transferred to any 2.5 ml culture, producing at most an increment of 10  -4 
#g ttSA/ml. As this was one-thousandth of the lowest antigen concentration employed, the 
amount of cell-bound antigen transferred should not have affected the results. 
RESULTS 
Immunologic  Response of Sensitized  and  Tolerant Animals.---The  immuno- 
logic response of animals receiving toleragenic and/or sensitizing injections of 
HSA are presented  in Table I  and  are similar  to those  reported in  previous 
studies  (20).  Delayed  skin  reactivity was  established  at  1 wk  in  all animals 
sensitized with  10 #g HSA in CFA. The diameter of cutaneous erythema was 
maximal at 1 wk, induration maximal at 2 wk, and necrosis apparent in a ma- 
jority of lesions at 4 wk after immunization. Intravenous administration  of 5 
mg HSA immediately before sensitization with antigen  in adjuvant abolished 
the  skin  test response  to HSA  at  2  wk.  Faint  cutaneous  erythema without 
induration  was elicited  at 4  wk,  and small, minimally indurated  lesions were 
observed at 8 wk.  Suppression of cutaneous reactivity with 500/zg HSA was 
less  complete.  Nonindurated  erythematous  reactions  appeared  at  2  wk  and 
slightly indurated  reactions  comparable in diameter  to controls developed at 
4  wk.  However, induration  failed to achieve control levels,  even at the 8 wk 
interval. Necrosis was not observed in reactions occurring in partially tolerant 
animals. 
Histologically,  characteristic  delayed  lesions  were  produced  in  sensitized 
animals at 2 and 4 wk, with extensive mononuclear infiltrates throughout the 
dermis,  subadjacent  fat,  and  muscle.  Test  sites  from fully  tolerant  animals 
lacked a  significant cellular infiltrate  (21).  Erythematons, nonindurated  reac- 
tions  observed in  animals recovering from tolerance,  obtained  2  wk  after  a 
500 #g suppressing injection or 4 wk after a 5 mg one, exhibited characteristic 
cutaneous  basophil  hypersensitivity  (CBH)  with  a  prominent  infiltrate  of R.  C.  BAST,  JR.,  E.  J.  MANSEAU~  AND  I-I.  F.  DVORAK  193 
basophilic leukocytes in addition to mononuclears. CBH has been observed at 
early intervals  after sensitization  with  antigens  in  either  Freund's  complete 
or Freund's incomplete adjuvant  (27),  but has not been noted previously in 
animals recovering from tolerance. At late intervals, the moderately indurated 
reactions observed on further recovery were similar histologically to the delayed 
TABLE  I 
Immunologic Response  of Sensitized  and  Tolerant Animals at Different  Intervals 
Following Immunization with 10 I~g HSA 
Delayed skin reactions* 
6/zg HSA  1:100 OT 
19+(12/12)  15+(12/12) 
20+++(13/13)  16++(13/13) 
15  o  (4/5)  18  +++ (5/5) 
20 (2/14)  18  ++ (14/14) 
21+++(6/6)  17+++(6/6) 
17o (8/8)  18  ++* (8/8) 
19+++N (10/10)  24+++N  (10/10) 
18  ++ (19/19)  23+++N  (19/19) 
80 (6/9)  22  +++ (9/9) 
20  +++ (7/7)  22++++N  (7/7) 
18  ++ (9/9)  20++++N (9/9) 
9=k (2]3)  19  +++ (3/3) 
Antibody Titers$ 
TCA 
0(2/6) 
320 (9/9) 
20(8/12) 
20 (6/12) 
280(6/6) 
40(7/8) 
320 (13/131 
80(10/101 
10 (5/9) 
160(7/7) 
160(10/101 
0(0/3) 
11/12 
o/9 
4/12 
10/12 
0/6 
4/8 
0/13 
0/9 
8/9 
1/7 
o/io 
1/3 
PCA  TCH 
:  =  AI  AI 
--  I  -- 
2 1/12 0/12 0/12  0(0/6) 
3/9  1/9  5/9  320 (9/9) 
5/12  3/12  0/12  10(5/12) 
2  1/12 0/12  1/12  0(0/12) 
0/6  5/6  1/6  640 (6/6) 
318  118  ot8  0(o/8) 
3/13  1/13 9/13  320(13/13) 
3/9  5/9  1/9  40(8/10) 
0/9  1/9  0/9  0(0/9) 
2/7  4/7  [I/7  160 (7/7) 
1/10 5/10 qlO  40(9/10) 
113  1/3  0/3  0(0/3) 
* Skin  reactions at 24 hr, expressed  as average diameter of erythema (mm) and mean degree of induration 
(0-++++). N indicates necrosis. Numbers in parentheses are fractions giving detectable responses. 
~; TCA, tanned cell hemagglutination, and TCH, tanned cell hemolysis. TCA and TCH expressed as reciprocal 
of titer. 0 is negative at a serum dilution of 1: 5. Numbers in parentheses are fractions of animals with detectable 
titers. PCA is expressed  as the fraction of animals responding  at different serum dilutions. 
reactions produced in sensitized animals at an earlier interval after sensitiza- 
tion. 
Tuberculin reactivity increased progressively with maximal erythema at 4, 
and maximal induration  at 8 wk. Necrosis was present at both of these inter- 
vals. Delayed cutaneous reactivity to tuberculin was not affected by suppressing 
injections of HSA. 
Though antibody could not be detected in sensitized animals at 1 wk by any 
of the methods employed, including  active systemic anaphylaxis,  titers were 
maximal at 2 wk and remained elevated for at least 8 wk. A 5 mg intravenous 
dose abolished ?2 production  and suppressed 71 in nearly all animals for the 19~  HETEROGENEITY  OF  THE  CELLULAR  IMMUNE  RESPONSE.  I 
duration of the experiment. With a 500 #g suppressing injection, hemagglutina- 
tion titers were significantly reduced, though not eliminated, at 2 and 4 wk, and 
eventually rose to control levels. PCA activity exhibited a similar pattern and 
actually exceeded control values at 8 wk. Hemolytic antibody remained de- 
pressed at all intervals. 
Antigen-Induced Thymidine Uptake by  Cells from Sensitized Animals.- 
Groups of from 5-12 guinea pigs were immunized with 10/~g HSA in CFA or 
with  CFA alone and cultures were prepared at 1,  2,  4,  and 8 wk  thereafter. 
Incorporation of tritiated thymidine by lymph node cells was measured in the 
absence or presence of different concentrations of HSA ranging from 10  -1  to 
10  -~ t~g/ml.  The effect of 10 #g PPD/ml was also studied. 
At  1 wk  after immunization, when  delayed cutaneous reactivity was  well 
established  and  antibody  not  yet  demonstrable,  a  statistically  significant 
(P -- 0.009) increase of thymidine incorporation could be achieved with 10 mg 
HSA/ml  (Fig.  1).  At subsequent intervals,  cells failed to react with  10 nag 
HSA/ml  but significant stimulation  could be  produced with as  little as  100 
ttg/ml at 2 wk and 0.1 ttg/ml at 4 and 8 wk (Figs. 1 and 2). Similiarly, 2-fold 
stimulation occurred at progressively lower concentrations of HSA, requiring 
10 mg/ml at 1 wk and only 10/~g/ml at 4 wk. Over the same interval the maxi- 
mal stinmlatory index increased from 2.4 at 1 wk to 6.6 at 4 wk. 
10 #g PPD/ml produced 4-, 5-, and 4-fold stimulation on the average at 2, 4, 
and 8 wk respectively. 
Antigen-Induced Thymidine Uptake by Cells  from Tolerant Animals.--Lymph 
node cells from animals rendered tolerant with 500 ttg or 5 mg HSA were cul- 
tured 2, 4, and 8 wk after sensitization and their responses were compared with 
those of cells from animals sensitized with HSA in adjuvant or with adjuvant 
alone (Fig. 2). 
A 5 mg intravenous injection of HSA administered at the time of sensitiza- 
tion eliminated an in vitro response to specific antigen at 2 wk over the entire 
range of concentrations tested,  correlating with  the complete suppression  of 
cutaneous reactivity and antibody production observed in vivo. By 4 wk sig- 
nificant stimulation could be achieved, but only with 1 mg HSA/ml. At this 
dose level the magnitude of response was significantly reduced relative to that 
of cells from sensitized animals that had not received a suppressing injection. 
Return of reactivity at high antigen concentration in vitro was associated with 
the appearance of a nonindurated CBH reaction while neither ~/1 nor "}'2 anti- 
body could be detected. At 8 wk, the magnitude of response with 1 mg HSA/ml 
could no longer be distinguished statistically from that of sensitized animals. 
However, cells from tolerant animals failed to react at all lower antigen con- 
centrations. 
Suppression  of  lymphocyte stimulation  varied  with  the  dose  of  antigen 
administered.  Following 500 #g of HSA,  tolerance was  less  complete and re- R.  C.  BAST,  JR.,  E.  J.  MANSEAU,  AND  H.  F.  DVORAK  195 
covery more rapid than that observed  after the larger  suppressing  dose. Sig- 
nificant stimulation was observed during the 2nd wk at 1 mg/ml, though not 
at lower antigen concentrations. The magnitude of response exhibited by sensi- 
tized ceils was significantly greater at both 100 #g and 1 mg/ml. By 4 wk the 
response of sensitized  and tolerant cells to 1 mg HSA/ml could no longer be 
distinguished statistically. Significant reactivity was present at HSA concen- 
trations as low as 10/zg/ml, indicating a progressive, though partial, recovery of 
response to moderate concentrations of antigen. Reactivity persisted  at high 
antigen concentration for at least 8 wk, but sensitized ceils still proved signifi- 
cantly more reactive at 0.1-10 ~g/ml, consistent with the conclusion that reac- 
tivity had been suppressed at low antigen concentration throughout the experi- 
ment. It may be significant  that the induration of cutaneous reactions  and 
hemolytic antibody titers also failed to achieve  control levels in the 500  ~g 
tolerant group,  while hemagglutinating and PCA titers equalled  or exceeded 
those of sensitized controls. 
Cells from all tolerant groups responded  to 10/~g PPD/ml with stimulation 
comparable to that observed in cells sensitized with HSA in CFA or with CFA 
alone, indicating that the suppression was antigen specific. 
Effect  of Mycobacteria on Sensitization  and Induction  of Tolerance.--Guinea 
pigs sensitized with 10/zg HSA in Freund's complete adjuvant containing 300 
#g  tubercle  bacilli/ml  (CFA  1:10)  developed  delayed cutaneous reactivity 
and antibody titers entirely comparable  to those of animals immunized with 
the adjuvant usually employed (Table I). However,  administration of a 5 mg 
intravenous injection at the time of sensitization failed to produce the complete 
suppression of cutaneous reactivity observed at 2 wk in animals sensitized with 
adjuvant containing the larger dose of tubercle bacilli. 
When studied in vitro (Fig.  2),  ceils from animals sensitized with HSA in 
CFA 1:10  2 wk earlier  could be stimulated with 10 mg HSA/ml while cells 
from guinea pigs  immunized with HSA in CFA failed to react at this high 
concentration of antigen. Both groups responded  to 10 and 100/~g HSA/ml. 
Following a 5 mg suppressing injection, lymphocyte stimulation was abolished 
in animals immunized with HSA in CFA, but could be elicited with 100 #g-10 
mg HSA/ml in the CFA 1  : 10 groups, correlating with the cutaneous reactions 
observed in vivo. 
DISCUSSION 
Data presented here document an evolution of the cellular immune response 
consistent with  the  selection  of  lymphoid cells by  exposure  to  decreasing 
concentrations of antigen in vivo (7). Within 1 wk of sensitization with HSA in 
CFA,  cells appeared  in draining lymph nodes  which  were  capable  of being 
stimulated in vitro with 10 mg HSA/ml. By 4 wk reactivity had disappeared 
at  this  high  antigen concentration, but  statistically significant  stimulation 196  HETEROGENEITY OF  THE  CELLULAR  IMMUNE  RESPONSE.  I 
could be produced over a  10,000-fold range from 1 mg/ml  to 0.1 /~g/ml.  Loss 
of reactivity at 10 mg/ml may reflect an early decrease in the concentration of 
immunizing antigen below a  threshold required to prime cells of the  "lowest 
affinity," associated with depletion of primed cells, through migration or death. 
Actual measurement of antigen accumulation in draining nodes after sensitiza- 
tion with HSA in CFA has demonstrated maximal antigen levels at 1 wk with a 
subsequent rapid decline (28). Cells  reacting at low antigen concentration ap- 
peared  only at  later  intervals  when  the  concentration  of HSA  in  vivo had 
fallen,  presumably  permitting  the  selective  proliferation  or  recruitment  of 
"higher affinity" cells. After 4 wk, reactivity was not observed at concentrations 
below 0.1 #g/ml and no further increase occurred in the magnitude of maximal 
stimulation. Attainment of an optimal cellular response by 4 wk may explain 
the inability of Paul et al.  (10)  to detect differences in  the reactivity of cells 
cultured at 7-19 days and at 5-7 months. 
Interpretation of our data in terms of an affinity model is complicated by the 
use of HSA,  a  protein antigen bearing multiple determinants.  In  our system 
development of reactivity at  low antigen  concentration might  represent  the 
cellular response to strong or abundant determinants, rather than the response 
of cells with high affinity for any single antigenic group. Similarly, the response 
at high antigen concentration could reflect stimulation of cells bearing receptors 
for weak or less  abundant  determinants of different specificities, rather than 
the contribution of cells of low affinity. In either event, the appearance with 
time of in vitro reactivity at progressively lower antigen concentration would 
reflect the antigen-mediated selection of reactive cells from a population hetero- 
geneous with  regard to  specificity for different determinants,  affinity for in- 
dividual  determinants,  or  both.  For  a  variety  of  conditions  our  data  have 
established the minimum antigen concentration at which cells are stinmlated in 
culture; however,  they afford no insight  into  the behavior of cells at  supra- 
threshold levels of antigen. Thus,  the greater stimulatory indices observed at 
high  antigen  concentrations might  reflect the presence in  lymph  nodes  of a 
large population of cells reactive only at high  antigen  concentrations; alter- 
natively, if cells continue to respond at antigen concentrations well above the 
minimum needed for stimulation,  these indices might reflect a  summation  of 
the proliferative activities of all cells whose threshold was exceeded. 
Lymphocytes derived from animals  rendered tolerant by  a  suitable  injec- 
tion  of  soluble  antigen  at  the  time  of  sensitization  were not  stimulated  by 
specific antigen in culture. This confirms earlier reports that cells from tolerant 
animals  remain specifically incompetent in vitro or  on  transfer to irradiated 
hosts  (29-33).  Suppression  of lymphocyte stimulation  by an intravenous in- 
jection of antigen proved to be a dose-related phenomenon exhibiting kinetics 
compatible with a  selection of cells by antigen. Administration of 5 mg HSA 
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tions employed in culture, while 500/~g HSA eliminated stimulation at low, 
but  not  at  the  highest  antigen  concentrations  over  this  interval.  Partially 
tolerant  animals  or  animals  beginning  to  recover  from  tolerance  possessed 
lymph node  cells  responsive  to  high  antigen  concentrations  and  developed 
CBH  (27).  With time, reactivity at lower HSA concentrations was  also ob- 
served. Similarities of the dose response curves at 4-8 wk after a 5 mg suppress- 
ing injection, 2-4 wk after 500 #g, or 1-2 wk after sensitization alone, suggest 
that  the  evolution of reactivity observed  after administration of antigen in 
adjuvant may simply be delayed in tolerant animals. However, recapitulation 
of the primary response was not complete in that reactivity did not return at 
the lowest antigen concentrations during the course of our study. This selective 
loss would be predicted if cells reacting at low antigen concentrations bound 
HSA most avidly and if such binding enhanced the toleragenic effect of antigen. 
Similarly, failure to induce complete tolerance in animals sensitized with HSA 
in  CFA  1:10 reflects the presence in such animals of large numbers of cells 
reactive only at high antigen concentrations, the cell population most difficult 
to render tolerant. The cellular kinetics observed are therefore reminiscent of 
the observations of Theis and Siskind (4) who found that the small amount of 
antibody formed by partially tolerant rabbits was of low average affinity and 
that affinity gradually rose with recovery from tolerance, eventually achieving 
values attained by normal animals much earlier in the course of sensitization. 
Similar data have been obtained in studies of antibody produced by tolerant 
animals sensitized with cross-reacting antigens (34). 
Extrapolations from studies of lymphocyte stimulation to an understanding 
of the heterogeneity of the humoral response are limited by the finding that 
antigen-induced thymidine incorporation correlates  temporally with delayed 
cutaneous reactivity rather than with elevations of antibody titer. Lymphocyte 
stimulation was produced at 1 wk after sensitization when cutaneous reactivity 
was  well established  in  the  absence  of  detectable  antibody,  confirming the 
report of Oppenheim in a hapten system (18). The appearance of lymphocyte 
reactivity 4 wk after a 5 mg suppressing injection correlated with the develop- 
ment of erythematous nonindurated skin reactions exhibiting the histology of 
CBH  (27).  Only minimal titers  of hemagglutinating antibody were  present 
at this time, hemolytic antibody could not be detected, and only one of nine 
sera had PCA activity. Histologically, the lymphocytes and blasts encountered 
in these cultures contained little endoplasmic reticulum and did not resemble 
plasma cell precursors3 While antibody can be produced by ceils resembling 
typical lymphocytes, only small amounts  of antibody have been detected in 
similar cultures despite numerous studies (35).  On the other hand, migration- 
inhibitory factor,  thought to be  a  mediator of delayed reactions in vivo,  is 
readily produced by lymph node cells in the presence of specific antigen (36). 
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Taken  together,  these  observations  point  to  an  association  of  lymphocyte 
stimulation in culture with cell-mediated events in vivo, a conclusion that will 
be discussed in the following paper (28). 
Insofar as lymphocyte stimulation correlates with cell-mediated irrmlunity, 
our data suggest one explanation for the relative ease with which tolerance to 
delayed reactivity can be produced in adult animals by a  single injection of 
antigen (20).  Standard delayed skin tests of 6 #g in 0.1ml  provide an initial 
local concentration of HSA no greater than 60/zg/ml. More than 50% of this 
dose is cleared from the test site by 6 hr when mononuclears begin to accumu- 
late,  and  more  than  90%  of injected antigen is  cleared within 24  hr  (21). 
Concentrations of antigen in situ, then, correspond to levels that stimulate cells 
reacting at relatively low antigen concentration in culture and these are pre- 
cisely the cells most readily eliminated by the intravenous injection of antigen. 
In fact, stimulation was not observed at antigen concentrations of less  than 
10/~g/ml in animals recovering from tolerance. If cells reacting at lower HSA 
levels  contribute  significantly to  delayed  lesions,  their  selective  loss  would 
explain the failure of tolerant animals to achieve indurated cutaneous reactions 
comparable to controls. 
Finally, it is worth noting that a 5 mg suppressing injection provides an adult 
guinea pig with initial plasma levels of approximately 250/~g HSA/ml. After 
24-48 hr this value falls to 25-50/zg/ml through equilibration with the extra- 
cellular fluid, catabolism, and excretion. Excluding the possibility of a mecha- 
nism enhancing the local concentration of antigen by some 1000-fold,  animals 
are rendered tolerant in vivo with concentrations of antigen producing lympho- 
cyte stimulation in  culture. These figures may help to explain the difficulty 
experienced by many workers in attempts to induce tolerance to heterologous 
serum proteins by exposure to antigen in vitro (30). Possibly an additional step 
of complexity is provided within the whole animal beyond the simple interac- 
tion  of  lymphocytes with  antigen.  Alternatively,  lymphocyte proliferation 
resembling  that  observed  in  culture  might  constitute a  critical  step  in  the 
development of tolerance. 
SUMMARY 
Lymph  node  cells  from  guinea  pigs  immunized  with  HSA  in  complete 
Freund's adjuvant were grown in cultures containing different concentrations 
of specific  antigen. Stimulation of thymidine incorporation was induced with 
progressively lower concentrations of HSA at successive intervals after sensi- 
tization. Moreover, the intensity of delayed skin reactions and the magnitude 
of stimulation in vitro increased over the same interval. These events are con- 
sidered compatible with an evolution of the cellular immune response resulting 
from the selection of lymphoid cells by decreasing concentrations of antigen in 
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Ceils from animals rendered  tolerant  to HSA failed  to  respond  to  specific 
antigen in culture. As tolerance waned,  stimulation was achieved at high but 
not low antigen concentrations. Tolerance, measured by cutaneous reactivity 
or by lymphocyte stimulation, was less readily induced  in animals sensitized 
with  adjuvant  containing  a  reduced  concentration  of mycobacteria. Lymph 
nodes from these animals contained a large population of cells reactive at high 
antigen  concentration,  presumably less  susceptible  to  the  toleragenic  effect 
of intravenous antigen. 
The dissociation of delayed hypersensitivity and antibody formation observed 
early in the immune response and upon recovery from tolerance has permitted 
correlation  of lymphocyte stimulation with  delayed hypersensitivity and  cu- 
taneous basophil hypersensitivity respectively. 
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